Nasopharyngeal Cancer: Is the Addition of Chemotherapy to Radiotherapy Worthwhile in an Era of Value-Based Care?

JCO Oncol Pract. 2020 Nov;16(11):711-712. doi: 10.1200/OP.20.00656. Epub 2020 Sep 18.

Authors

Victoria M Villaflor¹, Erminia Massarelli²

Affiliations

¹ Department of Medical Oncology, Northwestern University, Chicago, IL.
² Department of Medical Oncology and Therapeutics Research, City of Hope Cancer Center, Duarte, CA.

PMID: 32946323
DOI: 10.1200/OP.20.00656

No abstract available

Publication types

Editorial
Comment

MeSH terms

Chemoradiotherapy
Chemotherapy, Adjuvant
Humans
Induction Chemotherapy
Medical Oncology
Nasopharyngeal Neoplasms* / drug therapy
Nasopharyngeal Neoplasms* / radiotherapy